CASI Pharmaceuticals Inc (NASDAQ:CASI)
| 2.11 Delayed Data As of 3:59pm ET |  -0.02 / -0.94%Today’s Change | 2.04 Today|||52-Week Range 3.82 | -31.72% Year-to-Date |
Latest CASI News | Press Releases
No recent news for CASI Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.13 |
| Today’s open | 2.22 |
| Day’s range | 2.10 - 2.22 |
| Volume | 135,957 |
| Average volume (3 months) | 141,300 |
| Market cap | $204.3M |
Data as of 3:59pm ET, 02/24/2020
Growth & Valuation
| Earnings growth (last year) | -80.06% |
| Earnings growth (this year) | -19.90% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| THTXTheratechnologies In... | -0.24 | -8.92% |
| ABUSArbutus Biopharma Co... | -0.22 | -6.77% |
| LOGCLogicBio Therapeutic... | -0.23 | -2.63% |
| KLDOKaleido Biosciences ... | -0.23 | -3.22% |
Data as of 4:00pm ET, 02/24/2020
Financials
| Next reporting date | March 20, 2020 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$27.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
